20662 Federal Register / Vol. 66, No. 79 / Tuesday, April 24, 2001 / Notices

Human Immunodeficiency Virus (HIV)

and Sexually Transmitted Diseases

(STDs). This proposed data collection is

for the second phase of this 2-year

project. During the first phase questions

were developed and tested, and a

pretest of 203 interviews was

conducted. During this second phase a

pilot survey with a larger number of

respondents will be conducted, and a

small number of additional questions

will be included measuring HIV-related

stigma.

Knowledge about the level of HIV risk

behaviors in populations is essential for

effective HIV prevention programs.

Currently, survey-based assessment of

these behaviors depends on a range of

survey questions that differ across

surveys, and that are difficult to

compare and to reconcile. Therefore, the

Behavioral Surveillance Working Group,

coordinated by the National Center for

HIV, STD and Tuberculosis Prevention,

Centers for Disease Control and

Prevention, has developed a draft set of

items to be proposed as standard survey

questions on the topics of sexual

behavior, HIV testing, drug use, and

other behaviors related to risk of

contracting HIV and/or STDs. As part of

this effort, CDC will sponsor a

telephone-based pilot of 650 persons

aged 18–59, selected randomly from

within an urban area, in order to test

these questions.

Further, because some of the survey

questions are private and potentially

sensitive, the project will entail the

testing of a survey administration mode:

Telephone-based audio computerassisted self-interview (T–ACASI), in

which a computer will be used to

administer the most sensitive questions,

and in which the surveyed individual

enters responses directly onto the

telephone keypad. This procedure

eliminates the need for communication

of sensitive questions from the

interviewer to the respondent, as well as

the need for respondents to answer the

questions verbally. In order to test the

effectiveness of this procedure, half of

the interviews will be conducted using

the T–ACASI procedure for the most

sensitive questions, and half using

standard, interviewer-based

administration of all questions. Data

analysis will rely on an assessment of

the response rate under each mode, and

on the nature of the data obtained to the

sensitive questions. The larger sample

size of the year 2 pilot survey will

enable us to test statistical significance

of the effectiveness of the T–ACASI

procedure.

Information and data obtained from

this evaluation will help direct future

surveys, by determining whether it is

feasible to attempt to administer these

standard risk questions using a

telephone survey, and whether a T–

ACASI-based procedure represents a

technological innovation that will

positively contribute to such an effort,

through improvements in data quality.

The total annual burden is 217 hours.

Respondents No. of respondents

No. of responses/respondentAvg. burden per

response (in

hours)

Screening ......................................................................................................................... 3448 1 1/60

Interview ........................................................................................................................... 650 1 20/60

Dated: April 16, 2001.

Nancy Cheal,

Acting Associate Director for Policy Planning,

and Evaluation, Centers for Disease Control

and Prevention.

[FR Doc. 01–10061 Filed 4–23–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30-DAY–29–01]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Project: National Childhood

Blood Lead Surveillance System—

Renewal—(OMB No. 0920–0337),

National Center for Environmental

Health (NCEH), Centers for Disease

Control and Prevention (CDC). In 1992,

the Centers for Disease Control and

Prevention began the National

Childhood Lead Surveillance Program at

the National Center for Environmental

Health (NCEH). The goals of the

childhood lead surveillance program are

to (1) establish childhood lead

surveillance systems at the state and

national levels; (2) use surveillance data

to estimate the extent of elevated bloodlead levels among children; (3) assess

the follow-up of children with elevated

blood-lead levels; (4) examine potential

sources of lead exposure; and (5) help

allocate resources for lead poisoning

prevention activities. State surveillance

systems are based on reports of bloodlead tests from laboratories. Ideally

laboratories report results of all lead

tests, not just elevated values, to the

state health department, but each state

determines the reporting level for blood

lead tests. In addition to blood lead test

results, state child-specific surveillance

databases contain follow-up data on

children with elevated blood-lead levels

including data on medical treatment,

environmental investigations, and

potential sources of lead exposure.

Surveillance data for the national

database are extracted from the state

child-specific databases and transferred

to CDC.

OMB approval for this package will

expire on March 31, 2001. This request

is for a three-year renewal with a change

in the burden hours. The annual burden

hours are estimated to be 600.

Type of respondents

No. respondents

Frequency

of

responses

Avg.

burden/response

(in hrs)

State Health Departments:

(a) annual report ............ 28 1 10.0

(b) quarterly

report ......... 40 4 2.0

Dated: April 16, 2001.

Nancy E. Cheal,

Acting Associate Director for Policy Planning,

and Evaluation Centers for Disease Control

and Prevention (CDC).

[FR Doc. 01–10064 Filed 4–23–01; 8:45 am]

BILLING CODE 4163–18–P